Document Detail

Chemogenomics: a discipline at the crossroad of high throughput technologies, biomarker research, combinatorial chemistry, genomics, cheminformatics, bioinformatics and artificial intelligence.
MedLine Citation:
PMID:  18795877     Owner:  NLM     Status:  MEDLINE    
Chemogenomics is the study of the interaction of functional biological systems with exogenous small molecules, or in broader sense the study of the intersection of biological and chemical spaces. Chemogenomics requires expertises in biology, chemistry and computational sciences (bioinformatics, cheminformatics, large scale statistics and machine learning methods) but it is more than the simple apposition of each of these disciplines. Biological entities interacting with small molecules can be isolated proteins or more elaborate systems, from single cells to complete organisms. The biological space is therefore analyzed at various postgenomic levels (genomic, transcriptomic, proteomic or any phenotypic level). The space of small molecules is partially real, corresponding to commercial and academic collections of compounds, and partially virtual, corresponding to the chemical space possibly synthesizable. Synthetic chemistry has developed novel strategies allowing a physical exploration of this universe of possibilities. A major challenge of cheminformatics is to charter the virtual space of small molecules using realistic biological constraints (bioavailability, druggability, structural biological information). Chemogenomics is a descendent of conventional pharmaceutical approaches, since it involves the screening of chemolibraries for their effect on biological targets, and benefits from the advances in the corresponding enabling technologies and the introduction of new biological markers. Screening was originally motivated by the rigorous discovery of new drugs, neglecting and throwing away any molecule that would fail to meet the standards required for a therapeutic treatment. It is now the basis for the discovery of small molecules that might or might not be directly used as drugs, but which have an immense potential for basic research, as probes to explore an increasing number of biological phenomena. Concerns about the environmental impact of chemical industry open new fields of research for chemogenomics.
Eric Maréchal
Related Documents :
16231877 - Bioactive substances from insect pathogenic fungi.
11233767 - Neurodevelopmental effects: making the case for biologic plausibility.
3905297 - Chronomorphology--today.
19879427 - Conclusions and perspectives.
19030227 - Articles by latin american authors in prestigious journals have fewer citations.
16021767 - From single-channel recordings to brain-mapping devices: the impact of electroencephalo...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Combinatorial chemistry & high throughput screening     Volume:  11     ISSN:  1386-2073     ISO Abbreviation:  Comb. Chem. High Throughput Screen.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-09-17     Completed Date:  2008-10-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9810948     Medline TA:  Comb Chem High Throughput Screen     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  583-6     Citation Subset:  IM    
Unité mixte de recherche 5168 CNRS-CEA-INRA-Université Joseph Fourier, Institut de Recherches en Technologies et Sciences pour le Vivant, 17 avenue des Martyrs, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Artificial Intelligence*
Biological Markers / chemistry*
Combinatorial Chemistry Techniques*
Computational Biology*
Drug Design*
Genomics* / trends
Reg. No./Substance:
0/Biological Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A comparative analysis of standard microtiter plate reading versus imaging in cellular assays.
Next Document:  Expanding the chemical space in practice: diversity-oriented synthesis.